The company has launched its product, a generic version of Novartis Pharma AG#39;s Exjade tablets for oral suspension, after getting the nod from the United States Food and Drug Administration (USFDA), Dr Reddy#39;s Labs said in a filing to the BSE.Dr Reddy#39;s launches chronic iron overload treatment tablets in US
The company has launched its product, a generic version of Novartis Pharma AG#39;s Exjade tablets for oral suspension, after getting the nod from the United States Food and Drug Administration (USFDA), Dr Reddy#39;s Labs said in a filing to the BSE.
Subscribe to:
Post Comments (Atom)
-
"The (latest) investment will be used to grow the mobile esports format and establish presence in select overseas markets through its ...
-
The NCLT#39;s Ahmedabad bench has directed the RP to include GAIL in the list of creditors for both the companies.
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment